RMD
Resmed Stock Analysis
AI Rating
- Quality9/10
- Growth↑ 7/10
- Value↓ 3/10
RMD Growth
- Revenue Y/Y↑ 9.57%
- EPS Y/Y↑ 19.55%
- FCF Y/Y↑ 28.73%
RMD Profitability
- Gross margin ↑ 60.90%
- EPS margin↑ 27.50%
- ROIC 5Y↑ 39.16%
RMD Dividends
- Dividend yield 1.06%
- Growth 3Y↑ 10.83%
- Payout ratio↑ 22%
RMD Risk
- Debt / Equity↓ 0.1
- Debt / FCF↓ 0.0
- Interest coverage↑ 93.8
Resmed stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.